Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
| Treament | Trials | |||||
|---|---|---|---|---|---|---|
| clinical deterioration | clinical improvement | deaths | viral clearance | |||
| CoronaVac (SinoVac) | - | - | OBS 0.20 [0.14; 0.28], 1 study, I2=0% unassessable degree of certainty | - | ||
| Sinopharm Beijing (BBIBP-CorV) | - | - | - | - | ||
| Sinopharm Wuhan | - | - | - | - | ||
| Covaxin, Bharat Biotech (BBV152) | 0 | - | - | - | - | |
| Shifa-Pharmed inactivated vaccine | 0 | - | - | - | - | |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
